Browsing All Paterson Institute for Cancer Research by Authors
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.Gore, M; Szczylik, C; Porta, C; Bracarda, S; Bjarnason, G; Oudard, S; Lee, S; Haanen, J; Castellano, D; Vrdoljak, E; et al. (2015-06-30)We report final results with extended follow-up from a global, expanded-access trial that pre-regulatory approval provided sunitinib to metastatic renal cell carcinoma (mRCC) patients, ineligible for registration-directed trials.
A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (Suniforecast)Ahrens, M; Escudier, B; Boleti, E; Grimm, MO; Goupir, MG; Barthelemy, P; Gravis, G; Bedekes, J; Ivanyi, P; Panic, A; et al. (2020)